Editorial: Pip pip to <scp>PIP</scp>'s (post‐inflammatory polyps) as a neoplasia risk factor in <scp>IBD</scp>?-Reference-Cited by-同舟云学术

Editorial: Pip pip to PIP's (post‐inflammatory polyps) as a neoplasia risk factor in IBD?

Published:2023-07-15 Issue:3 Volume:58 Page:361-362
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Velayos Fernando S.¹

Affiliation:

1. Department of Gastroenterology and Hepatology Kaiser Permanente San Francisco Medical Center San Francisco California USA

Abstract

LINKED CONTENTThis article is linked to Wolf et al papers. To view these articles, visit https://doi.org/10.1111/apt.17495 and https://doi.org/10.1111/apt.17612

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17565

Reference10 articles.

1. Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing

2. Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study

3. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk

4. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis

5. No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Pip pip to PIPs (post‐ inflammatory polyps) as a neoplasia risk factor in IBD? Authors' reply;Alimentary Pharmacology & Therapeutics;2023-07-15